Ropes & Gray Advises Vaoptherm in its IPO
Ropes & Gray advised medical device company Vapotherm Inc. in connection with a $56 million initial public offering. The company will use the proceeds on sales and marketing staff, expanding marketing programs and research and development. Shares debuted on the New York Stock Exchange on Nov. 14, trading under the symbol VAPO.
Vapotherm makes noninvasive breathing aids, sold primarily to hospitals, to treat respiratory distress including heart failure, chronic obstructive pulmonary disease, asthma and pneumonia.
The Ropes & Gray team was led by life sciences partners Steven Wilcox and Michael Beauvais and securities & public companies counsel Thomas Danielski (all of Boston). The team also included tax & benefits partners Renata Ferrari and Aaron Harsh, and health care partner Eve Brunts (all of Boston), and life sciences partner Albert Cacozza (Washington, D.C.).